Iconic project

We are Dei BioPharma

Africa’s first iconic projects and has five more components than what Mordena is putting up in Kenya

OUR STORY

Dei BioPharma Ltd is a biotech and pharmaceutical research firm duly incorporated in Uganda, specializing in the development and manufacture of innovative medicines and vaccines. The company is currently developing an iconic drugs and vaccines manufacturing facility situated at Mattuga, Wakiso District, Uganda, and the state-of-the-art facility is valued at USD 1.1 billion.

Low cost drugs

The manufacturing facility is gearing to produce one billion doses of mRNA vaccines guided by the most stringent global GMP, including the US FDA, EU (EMA), and the World Health Organization (WHO) standards. Dei Biopharma Ltd is currently valued at USD 2.5 billion.

Who we are

The development of our iconic drugs and vaccines manufacturing facility situated at Mattuga, Wakiso District, near Kampala in Uganda, was commissioned on July 6, 2021, by President Yoweri Museveni and Kenya President William Ruto (then Vice President).

Vaccines Manufacturing Plant, located at Matugga

What Experts
Think About Us

Experts say the locally produced drugs would be cheaper.

Plant Assessment

The plant meets world standards, adding that the practice of making drugs within the country will solve the problem of fake drugs in Africa. “This plant meets the world standards, at least the first bits that I have seen…. Local production is one of the ways of solving the problem of fake drugs so that the population consumes the right medicine.”

Prof. John B. Kaneene

Entrepreneurs

A member of the board on combating substandard medical products said that in several African countries, falsified medicines account for between 30% and 60% of all the medical products. Mr. Mbabazi says that Dei Biopharma Ltd is different from other foreign biotechnology companies such as Moderna that are being hosted by African countries.

John Patrick Amama Mbabazi
Dei BioPharma Ltd.